Summary

According to our new research study on “Tracheostomy Market Forecast to 2031 –Global Analysis – by Type, Technique, End User, and Geography,” the market is anticipated to grow from US$ 782.91 million in 2023 and is projected to reach US$ 1,263.65 million by 2031; it is expected to register a CAGR of 6.2% during 2023–2031. The increasing prevalence of respiratory diseases and the growing geriatric population are contributing to the growing tracheostomy market size. However, complications associated with tracheostomy hamper the market growth. Further, technological advancements in tracheostomy devices and procedures are expected to bring new tracheostomy market trends in the coming years.

North America accounted for a major share of the global tracheostomy market in 2023. The North America tracheostomy market is segmented into the US, Canada, and Mexico. The US is one of the most developed countries in North America. A tracheostomy is a medical surgery in which the airway is directly accessed by creating a hole in the front of the neck into the trachea. It is frequently carried out in situations involving airway obstruction, respiratory failure, trauma, or extended mechanical ventilation. An article in Critical Care Medicine 2020 states that ~100,000 tracheostomies are performed in the US each year.

Government activities aimed at addressing the product shortage are expected to generate growth opportunities for the market in the near future. The U.S. Food and Drug Administration (FDA) informed patients, caregivers, and healthcare providers in October 2022 that there was a shortage of tracheostomy tubes, particularly ICU Medical's Bivona tracheostomy tubes. Pediatric patients were more likely to be affected by a Bivona tracheostomy tube scarcity since there were not as many substitute tubes available with comparable functioning.

The need for tracheostomy treatments is on the rise due to an increase in the prevalence of chronic respiratory conditions such as asthma, obstructive sleep apnea, and chronic obstructive pulmonary disease (COPD). The Asthma Canada Annual Report 2021 states that over 850,000 children under the age of 14 have asthma, making it one of the most prevalent chronic illnesses in children and a significant contributor to hospitalization and absenteeism from school. Severe asthma, which affects an estimated 150,000–250,000 Canadians.

Improved training programs for medical professionals, such as doctors, nurses, and respiratory therapists, in carrying out and overseeing tracheostomy procedures increased the acceptance rate. Therefore, there is a growing understanding among medical professionals of the advantages of early tracheostomy in critically sick patients, which lowers difficulties related to ventilator use and enhances patient outcomes. Thus, rising rates of respiratory illnesses and increasing awareness of tracheostomy advantages contribute to the market's expansion.

The rising use of tracheostomy operations and devices is partly due to the private healthcare sector in Mexico, which frequently has access to more cutting-edge medical technologies than public facilities. For instance, tracheostomy penetration rates are higher in larger hospitals and specialty clinics in locations such as Guadalajara, Monterrey, and Mexico City. Moreover, the Mexican government has been putting healthcare reforms into effect with the goal of enhancing access to high-quality medical care, which may have a favorable impact on the availability of tracheostomy services throughout the nation. This plan includes growing critical care units and purchasing cutting-edge medical equipment.

Growing Number of Initiatives and Awareness Programs to Provide Market Opportunities in Future

A few government initiatives are focused on improving accessibility and promoting innovation in the field of tracheostomy. For instance, the Global Tracheostomy Collaborative (GTC) is a quality improvement collaborative that offers the best tracheostomy care across the globe and helps staff, managers, patients, and their families rapidly implement the best practices into healthcare settings. This collaboration aims to work together to enhance the care, safety, and quality of life of patients undergoing tracheostomy. The 8th International Symposium by GTC will be conducted in November 2024 and will focus on delivering safe, effective tracheostomy care on a global scale, achieved through data-driven innovations of interprofessional teams of physicians, nurses, respiratory therapists, speech therapists, patients, and families.

Further, global tracheostomy tube awareness week was conducted from May 15–21 in 2022 by the Tracheostomy Education institution. The campaign aimed at increasing awareness about individuals with tracheostomy among their families and caregivers across the globe. In addition, the Joint Faculty of Intensive Care Medicine of Ireland conducted National Critical Care Tracheostomy Day on January 17, 2024, which aimed to provide education on multidisciplinary care, best practices, and insights from experts in the field of tracheostomy.

 

Tracheostomy Market: Competitive Landscape and Key Developments

Medtronic Plc, ICU Medical Inc, Coloplast Corp, Fisher & Paykel Healthcare Corp Ltd, Teleflex Inc, Cook Medical Holdings LLC, Troge Medical GmbH, Fuji Systems Corp, Andreas Fahl Medizintechnik-Vertrieb GmbH, Medis Medical (Tianjin) Company Ltd, Boston Medical Products, Well Lead Medical Co. Ltd., Intersurgical Ltd, KAPITEX Healthcare Ltd, VBM Medizintechnik GmbH, SunMed Group Holdings LLC, AdvaCare Pharma USA LLC, and Angiplast Private Limited are among the key companies operating in the tracheostomy market.

The US Food and Drug Administration, Centers for Disease Control and Prevention (CDC), and American Society for Clinical Trials are among the primary and secondary sources referred to while preparing the tracheostomy market report.

ページTOPに戻る

Table of Contents

TABLE OF CONTENTS

1. Introduction
1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Insights
3. Research Methodology
3.1 Secondary Research
3.2 Primary Research
3.2.1 Hypothesis formulation:
3.2.2 Macro-economic factor analysis:
3.2.3 Developing base number:
3.2.4 Data Triangulation:
3.2.5 Country level data:
4. Tracheostomy Market Landscape
4.1 Overview
4.2 PEST Analysis
5. Tracheostomy Market – Key Market Dynamics
5.1 Tracheostomy Market – Key Market Dynamics
5.2 Market Drivers
5.2.1 Increasing Prevalence of Respiratory Diseases
5.2.2 Growing Geriatric Population
5.3 Market Restraints
5.3.1 Complications Associated with Tracheostomy
5.4 Market Opportunities
5.4.1 Growing Number of Initiatives and Awareness Programs
5.5 Future Trends
5.5.1 Technological Advancements in Tracheostomy Devices and Procedures
5.6 Impact of Drivers and Restraints:
6. Tracheostomy Market – Global Market Analysis
6.1 Tracheostomy Market Revenue (US$ Million), 2021–2031
6.2 Tracheostomy Market Forecast Analysis
7. Tracheostomy Market Analysis – by Type
7.1 Tracheostomy Tubes
7.1.1 Overview
7.1.2 Tracheostomy Tubes: Tracheostomy Market – Revenue and Forecast to 2031 (US$ Million)
7.2 Tracheostomy Ventilation Accessories
7.2.1 Overview
7.2.2 Tracheostomy Ventilation Accessories: Tracheostomy Market – Revenue and Forecast to 2031 (US$ Million)
7.3 Other Accessories
7.3.1 Overview
7.3.2 Other Accessories: Tracheostomy Market – Revenue and Forecast to 2031 (US$ Million)
7.4 Tracheostomy Clean and Care Kits
7.4.1 Overview
7.4.2 Tracheostomy Clean and Care Kits: Tracheostomy Market – Revenue and Forecast to 2031 (US$ Million)
8. Tracheostomy Market Analysis – by Technique
8.1 Surgical Tracheostomy
8.1.1 Overview
8.1.2 Surgical Tracheostomy: Tracheostomy Market – Revenue and Forecast to 2031 (US$ Million)
8.2 Percutaneous Dilatational Tracheostomy
8.2.1 Overview
8.2.2 Percutaneous Dilatational Tracheostomy: Tracheostomy Market – Revenue and Forecast to 2031 (US$ Million)
9. Tracheostomy Market Analysis – by End User
9.1 Hospitals and Surgery Centers
9.1.1 Overview
9.1.2 Hospitals and Surgery Centers: Tracheostomy Market – Revenue and Forecast to 2031 (US$ Million)
9.2 Ambulatory Care Centers
9.2.1 Overview
9.2.2 Ambulatory Care Centers: Tracheostomy Market – Revenue and Forecast to 2031 (US$ Million)
9.3 Home Care Settings
9.3.1 Overview
9.3.2 Home Care Settings: Tracheostomy Market – Revenue and Forecast to 2031 (US$ Million)
9.4 Research Laboratories and Academic Institutes
9.4.1 Overview
9.4.2 Research Laboratories and Academic Institutes: Tracheostomy Market – Revenue and Forecast to 2031 (US$ Million)
10. Tracheostomy Market – Geographical Analysis
10.1 North America
10.1.1 North America Tracheostomy Market Overview
10.1.2 North America: Tracheostomy Market – Revenue and Forecast to 2031 (US$ Million)
10.1.2.1 North America: Tracheostomy Market – Revenue and Forecast Analysis – by Type
10.1.2.2 North America: Tracheostomy Market – Revenue and Forecast Analysis – by Technique
10.1.2.3 North America: Tracheostomy Market – Revenue and Forecast Analysis – by End User
10.1.3 North America: Tracheostomy Market – Revenue and Forecast Analysis – by Country
10.1.3.1 United States: Tracheostomy Market – Revenue and Forecast to 2031 (US$ Million)
10.1.3.1.1 United States: Tracheostomy Market Breakdown, by Type
10.1.3.1.2 United States: Tracheostomy Market Breakdown, by Technique
10.1.3.1.3 United States: Tracheostomy Market Breakdown, by End User
10.1.3.2 Canada: Tracheostomy Market – Revenue and Forecast to 2031 (US$ Million)
10.1.3.2.1 Canada: Tracheostomy Market Breakdown, by Type
10.1.3.2.2 Canada: Tracheostomy Market Breakdown, by Technique
10.1.3.2.3 Canada: Tracheostomy Market Breakdown, by End User
10.1.3.3 Mexico: Tracheostomy Market – Revenue and Forecast to 2031 (US$ Million)
10.1.3.3.1 Mexico: Tracheostomy Market Breakdown, by Type
10.1.3.3.2 Mexico: Tracheostomy Market Breakdown, by Technique
10.1.3.3.3 Mexico: Tracheostomy Market Breakdown, by End User
10.2 Europe
10.2.1 Europe Tracheostomy Market Overview
10.2.2 Europe: Tracheostomy Market – Revenue and Forecast to 2031 (US$ Million)
10.2.2.1 Europe: Tracheostomy Market – Revenue and Forecast Analysis – by Type
10.2.2.2 Europe: Tracheostomy Market – Revenue and Forecast Analysis – by Technique
10.2.2.3 Europe: Tracheostomy Market – Revenue and Forecast Analysis – by End User
10.2.3 Europe: Tracheostomy Market – Revenue and Forecast Analysis – by Country
10.2.3.1 Germany: Tracheostomy Market – Revenue and Forecast to 2031 (US$ Million)
10.2.3.1.1 Germany: Tracheostomy Market Breakdown, by Type
10.2.3.1.2 Germany: Tracheostomy Market Breakdown, by Technique
10.2.3.1.3 Germany: Tracheostomy Market Breakdown, by End User
10.2.3.2 France: Tracheostomy Market – Revenue and Forecast to 2031 (US$ Million)
10.2.3.2.1 France: Tracheostomy Market Breakdown, by Type
10.2.3.2.2 France: Tracheostomy Market Breakdown, by Technique
10.2.3.2.3 France: Tracheostomy Market Breakdown, by End User
10.2.3.3 United Kingdom: Tracheostomy Market – Revenue and Forecast to 2031 (US$ Million)
10.2.3.3.1 United Kingdom: Tracheostomy Market Breakdown, by Type
10.2.3.3.2 United Kingdom: Tracheostomy Market Breakdown, by Technique
10.2.3.3.3 United Kingdom: Tracheostomy Market Breakdown, by End User
10.2.3.4 Italy: Tracheostomy Market – Revenue and Forecast to 2031 (US$ Million)
10.2.3.4.1 Italy: Tracheostomy Market Breakdown, by Type
10.2.3.4.2 Italy: Tracheostomy Market Breakdown, by Technique
10.2.3.4.3 Italy: Tracheostomy Market Breakdown, by End User
10.2.3.5 Spain: Tracheostomy Market – Revenue and Forecast to 2031 (US$ Million)
10.2.3.5.1 Spain: Tracheostomy Market Breakdown, by Type
10.2.3.5.2 Spain: Tracheostomy Market Breakdown, by Technique
10.2.3.5.3 Spain: Tracheostomy Market Breakdown, by End User
10.2.3.6 Rest of Europe: Tracheostomy Market – Revenue and Forecast to 2031 (US$ Million)
10.2.3.6.1 Rest of Europe: Tracheostomy Market Breakdown, by Type
10.2.3.6.2 Rest of Europe: Tracheostomy Market Breakdown, by Technique
10.2.3.6.3 Rest of Europe: Tracheostomy Market Breakdown, by End User
10.3 Asia Pacific
10.3.1 Asia Pacific Tracheostomy Market Overview
10.3.2 Asia Pacific: Tracheostomy Market – Revenue and Forecast to 2031 (US$ Million)
10.3.2.1 Asia Pacific: Tracheostomy Market – Revenue and Forecast Analysis – by Type
10.3.2.2 Asia Pacific: Tracheostomy Market – Revenue and Forecast Analysis – by Technique
10.3.2.3 Asia Pacific: Tracheostomy Market – Revenue and Forecast Analysis – by End User
10.3.3 Asia Pacific: Tracheostomy Market – Revenue and Forecast Analysis – by Country
10.3.3.1 China: Tracheostomy Market – Revenue and Forecast to 2031 (US$ Million)
10.3.3.1.1 China: Tracheostomy Market Breakdown, by Type
10.3.3.1.2 China: Tracheostomy Market Breakdown, by Technique
10.3.3.1.3 China: Tracheostomy Market Breakdown, by End User
10.3.3.2 Japan: Tracheostomy Market – Revenue and Forecast to 2031 (US$ Million)
10.3.3.2.1 Japan: Tracheostomy Market Breakdown, by Type
10.3.3.2.2 Japan: Tracheostomy Market Breakdown, by Technique
10.3.3.2.3 Japan: Tracheostomy Market Breakdown, by End User
10.3.3.3 India: Tracheostomy Market – Revenue and Forecast to 2031 (US$ Million)
10.3.3.3.1 India: Tracheostomy Market Breakdown, by Type
10.3.3.3.2 India: Tracheostomy Market Breakdown, by Technique
10.3.3.3.3 India: Tracheostomy Market Breakdown, by End User
10.3.3.4 Australia: Tracheostomy Market – Revenue and Forecast to 2031 (US$ Million)
10.3.3.4.1 Australia: Tracheostomy Market Breakdown, by Type
10.3.3.4.2 Australia: Tracheostomy Market Breakdown, by Technique
10.3.3.4.3 Australia: Tracheostomy Market Breakdown, by End User
10.3.3.5 South Korea: Tracheostomy Market – Revenue and Forecast to 2031 (US$ Million)
10.3.3.5.1 South Korea: Tracheostomy Market Breakdown, by Type
10.3.3.5.2 South Korea: Tracheostomy Market Breakdown, by Technique
10.3.3.5.3 South Korea: Tracheostomy Market Breakdown, by End User
10.3.3.6 Rest of APAC: Tracheostomy Market – Revenue and Forecast to 2031 (US$ Million)
10.3.3.6.1 Rest of APAC: Tracheostomy Market Breakdown, by Type
10.3.3.6.2 Rest of APAC: Tracheostomy Market Breakdown, by Technique
10.3.3.6.3 Rest of APAC: Tracheostomy Market Breakdown, by End User
10.4 Middle East and Africa
10.4.1 Middle East and Africa Tracheostomy Market Overview
10.4.2 Middle East and Africa: Tracheostomy Market – Revenue and Forecast to 2031 (US$ Million)
10.4.2.1 Middle East and Africa: Tracheostomy Market – Revenue and Forecast Analysis – by Type
10.4.2.2 Middle East and Africa: Tracheostomy Market – Revenue and Forecast Analysis – by Technique
10.4.2.3 Middle East and Africa: Tracheostomy Market – Revenue and Forecast Analysis – by End User
10.4.3 Middle East and Africa: Tracheostomy Market – Revenue and Forecast Analysis – by Country
10.4.3.1 Middle East and Africa: Tracheostomy Market – Revenue and Forecast Analysis – by Country
10.4.3.2 Saudi Arabia: Tracheostomy Market – Revenue and Forecast to 2031 (US$ Million)
10.4.3.2.1 Saudi Arabia: Tracheostomy Market Breakdown, by Type
10.4.3.2.2 Saudi Arabia: Tracheostomy Market Breakdown, by Technique
10.4.3.2.3 Saudi Arabia: Tracheostomy Market Breakdown, by End User
10.4.3.3 South Africa: Tracheostomy Market – Revenue and Forecast to 2031 (US$ Million)
10.4.3.3.1 South Africa: Tracheostomy Market Breakdown, by Type
10.4.3.3.2 South Africa: Tracheostomy Market Breakdown, by Technique
10.4.3.3.3 South Africa: Tracheostomy Market Breakdown, by End User
10.4.3.4 United Arab Emirates: Tracheostomy Market – Revenue and Forecast to 2031 (US$ Million)
10.4.3.4.1 United Arab Emirates: Tracheostomy Market Breakdown, by Type
10.4.3.4.2 United Arab Emirates: Tracheostomy Market Breakdown, by Technique
10.4.3.4.3 United Arab Emirates: Tracheostomy Market Breakdown, by End User
10.4.3.5 Rest of Middle East and Africa: Tracheostomy Market – Revenue and Forecast to 2031 (US$ Million)
10.4.3.5.1 Rest of Middle East and Africa: Tracheostomy Market Breakdown, by Type
10.4.3.5.2 Rest of Middle East and Africa: Tracheostomy Market Breakdown, by Technique
10.4.3.5.3 Rest of Middle East and Africa: Tracheostomy Market Breakdown, by End User
10.5 South and Central America
10.5.1 South and Central America Tracheostomy Market Overview
10.5.2 South and Central America: Tracheostomy Market – Revenue and Forecast to 2031 (US$ Million)
10.5.2.1 South and Central America: Tracheostomy Market – Revenue and Forecast Analysis – by Type
10.5.2.2 South and Central America: Tracheostomy Market – Revenue and Forecast Analysis – by Technique
10.5.2.3 South and Central America: Tracheostomy Market – Revenue and Forecast Analysis – by End User
10.5.3 South and Central America: Tracheostomy Market – Revenue and Forecast Analysis – by Country
10.5.3.1 Brazil: Tracheostomy Market – Revenue and Forecast to 2031 (US$ Million)
10.5.3.1.1 Brazil: Tracheostomy Market Breakdown, by Type
10.5.3.1.2 Brazil: Tracheostomy Market Breakdown, by Technique
10.5.3.1.3 Brazil: Tracheostomy Market Breakdown, by End User
10.5.3.2 Argentina: Tracheostomy Market – Revenue and Forecast to 2031 (US$ Million)
10.5.3.2.1 Argentina: Tracheostomy Market Breakdown, by Type
10.5.3.2.2 Argentina: Tracheostomy Market Breakdown, by Technique
10.5.3.2.3 Argentina: Tracheostomy Market Breakdown, by End User
10.5.3.3 Rest of South and Central America: Tracheostomy Market – Revenue and Forecast to 2031 (US$ Million)
10.5.3.3.1 Rest of South and Central America: Tracheostomy Market Breakdown, by Type
10.5.3.3.2 Rest of South and Central America: Tracheostomy Market Breakdown, by Technique
10.5.3.3.3 Rest of South and Central America: Tracheostomy Market Breakdown, by End User
11. Tracheostomy Market – Industry Landscape
11.1 Overview
11.2 Growth Strategies in Tracheostomy Market
11.3 Organic Growth Strategies
11.3.1 Overview
11.4 Inorganic Growth Strategies
11.4.1 Overview
12. Company Profiles
12.1 Medtronic Plc
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 ICU Medical Inc
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 Coloplast Corp
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 Fisher & Paykel Healthcare Corp Ltd
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 Teleflex Inc
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 Cook Medical Holdings LLC
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments
12.7 Troge Medical GmbH
12.7.1 Key Facts
12.7.2 Business Description
12.7.3 Products and Services
12.7.4 Financial Overview
12.7.5 SWOT Analysis
12.7.6 Key Developments
12.8 Fuji Systems Corporation
12.8.1 Key Facts
12.8.2 Business Description
12.8.3 Products and Services
12.8.4 Financial Overview
12.8.5 SWOT Analysis
12.8.6 Key Developments
12.9 Andreas Fahl Medizintechnik-Vertrieb GmbH
12.9.1 Key Facts
12.9.2 Business Description
12.9.3 Products and Services
12.9.4 Financial Overview
12.9.5 SWOT Analysis
12.9.6 Key Developments
12.10 Tianjin Medis Medical Device Co. Ltd.
12.10.1 Key Facts
12.10.2 Business Description
12.10.3 Products and Services
12.10.4 Financial Overview
12.10.5 SWOT Analysis
12.10.6 Key Developments
12.11 Boston Medical Products Inc
12.11.1 Key Facts
12.11.2 Business Description
12.11.3 Products and Services
12.11.4 Financial Overview
12.11.5 SWOT Analysis
12.11.6 Key Developments
12.12 Well Lead Medical Co. Ltd.
12.12.1 Key Facts
12.12.2 Business Description
12.12.3 Products and Services
12.12.4 Financial Overview
12.12.5 SWOT Analysis
12.12.6 Key Developments
12.13 Intersurgical Ltd
12.13.1 Key Facts
12.13.2 Business Description
12.13.3 Products and Services
12.13.4 Financial Overview
12.13.5 SWOT Analysis
12.13.6 Key Developments
12.14 Kapitex Healthcare Limited
12.14.1 Key Facts
12.14.2 Business Description
12.14.3 Products and Services
12.14.4 Financial Overview
12.14.5 SWOT Analysis
12.14.6 Key Developments
12.15 VBM Medizintechnik GmbH
12.15.1 Key Facts
12.15.2 Business Description
12.15.3 Products and Services
12.15.4 Financial Overview
12.15.5 SWOT Analysis
12.15.6 Key Developments
12.16 SunMed Group Holdings LLC ( AirLife)
12.16.1 Key Facts
12.16.2 Business Description
12.16.3 Products and Services
12.16.4 Financial Overview
12.16.5 SWOT Analysis
12.16.6 Key Developments
12.17 AdvaCare Pharma USA LLC
12.17.1 Key Facts
12.17.2 Business Description
12.17.3 Products and Services
12.17.4 Financial Overview
12.17.5 SWOT Analysis
12.17.6 Key Developments
12.18 Angiplast
12.18.1 Key Facts
12.18.2 Business Description
12.18.3 Products and Services
12.18.4 Financial Overview
12.18.5 SWOT Analysis
12.18.6 Key Developments
13. Appendix
13.1 About The Insight Partners
13.2 Glossary of Terms for Tracheostomy Market